Marson, Leziel Mae .
HRN: 26-00-41 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/06/2024
CEFUROXIME 1.5GM (VIAL)
10/06/2024
10/07/2024
IV
1500mg
Every 8 Hours
S/P LSTCS
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes